Biocryst (BCRX) Shares Surge 28+% Following Data from Studies of BCX5191

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY

6. SPCX
7. AVGO
8. RMAX
9. HD
10. BJ

February 15, 2012 7:34 AM EST

Price: $9.55 -1.14%

Overall Analyst Rating:
SELL (= Flat)

Shares of Biocryst Pharma (Nasdaq: BCRX) are up more than 28 percent Wednesday morning following encouraging data from studies of BCX5191. The stock last traded at $4.72.

FDA, Momentum Movers

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!